发明名称 HYDROLYSIS OF [R(R*,R*)]-2 -(4-FLUOROPHENYL) -BETA, DELTA -DIHYDROXY- 5-(1-METHYLETHYL) -3-PHENYL-4 -[(PHENYLAMINO) CARBONYL]- 1H-PYRROLE-1 -HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE.
摘要 <p>The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected bgr;,dgr;-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.</p>
申请公布号 MXPA03004276(A) 申请公布日期 2005.04.29
申请号 MX2003PA04276 申请日期 2001.10.24
申请人 TEVA PHARMACEUTICAL INDUSTRIES, LTD. 发明人 ISHAI, ETI
分类号 A61K9/28;A61K9/50;C07B53/00;C07B61/00;C07D207/34;C07D209/24;C07D213/55;C07D215/14;C07D239/42;C07D403/06;C07D405/06;(IPC1-7):C07D403/06 主分类号 A61K9/28
代理机构 代理人
主权项
地址